ArticleAging cell2026
MTR4: A Conserved Youth Factor for Vascular Endothelium.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Vascular endothelial cell (VEC) senescence drives organismal aging and age-related pathologies, yet the intrinsic factors preserving endothelial youthfulness remain poorly defined. Here, we identify MTR4, an evolutionarily conserved RNA helicase and nuclear RNA exosome cofactor, as a novel regulator of VEC senescence. MTR4 protein declines markedly in senescent HUVECs and aged mouse aortas, independent of general cell cycle exit. Mechanistically, senescence-induced upregulation of the E3 ubiquitin ligase synoviolin 1 (SYVN1) promotes K638-linked ubiquitination and proteasomal degradation of MTR4. MTR4 depletion drives proliferating HUVECs into premature senescence, whereas its overexpression restores a youthful phenotype in senescent cells by binding BUB3 to stabilize BUB3 and sustain BUBR1 expression. In mice, endothelial Mtr4 knockdown promotes vascular dysfunction and multi-organ aging, while endothelium-specific Mtr4 overexpression alleviates these phenotypes. In C. elegans, mtr-4 overexpression dramatically extends lifespan, comparable to classic longevity models and surpassing most single-gene interventions, while its knockdown accelerates aging. Our findings establish MTR4 as a critical guardian of endothelial homeostasis and organismal aging, with strong translational potential for mitigating age-related vascular dysfunction.
Indexed as
Identifiers
42885357What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.